''''Linagliptin and Metformin Hydrochloride""

Linagliptin and Metformin Hydrochloride
LINALIGLIP 2.5/500  are two different medications used to treat type 2 diabetes.
Linagliptin: It is an oral medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. Linagliptin works by inhibiting the action of the DPP-4 enzyme, which is responsible for breaking down incretin hormones like GLP-1 (glucagon-like peptide-1). GLP-1 helps regulate blood sugar levels by increasing insulin secretion and reducing glucagon release from the pancreas, ultimately leading to better control of blood glucose levels. Linagliptin is typically prescribed as an adjunct to diet and exercise in patients with type 2 diabetes. It is usually taken once a day.
Metformin Hydrochloride: Metformin is a widely used oral medication for the treatment of type 2 diabetes. It belongs to the class of medications known as biguanides. Metformin primarily works by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues, like muscle cells. It does not increase insulin secretion from the pancreas. Metformin is often used as a first-line treatment for type 2 diabetes and is also used to manage polycystic ovary syndrome (PCOS) and other conditions associated with insulin resistance.
Sometimes, these two medications are prescribed together as a combination therapy for individuals with type 2 diabetes who require additional glycemic control beyond what can be achieved with either medication alone. LINALIGLIP 2.5/500  combination can have synergistic effects, addressing different aspects of glucose regulation. By using LINALIGLIP 2.5/500  together, healthcare providers aim to achieve better blood sugar control and reduce the risk of complications associated with uncontrolled diabetes.
For further information please contact: 
info@sterispharma.com 
order now: - https://www.sterisonline.com/product/linaliglip-2-5-500-134273